Clinical Trial Update: C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating C1 esterase inhibitor for prevention of acute attacks in hereditary angioedema has completed with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• C1 Esterase Inhibitor (C1INH-nf) (C1 esterase inhibitor)

Snippet

Sponsor: Shire | Conditions: Hereditary Angioedema | Phase 3 | Status: COMPLETED | Results posted: 2010-06-03